Showing results (51-60 of 901) with videos related to
Sort By:
Pageof 91
Journal of Clinical Pathology|June 1, 1997
Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosisJ D Cartledge, J Midgely, B G GazzardThe Journal of Antimicrobial Chemotherapy|May 1, 1999
Non-albicans oral candidosis in HIV-positive patientsJ D Cartledge, J Midgley, B G GazzardGut|August 1, 1975
The use of fresh frozen plasma or a concentrate of factor IX as replacement therapy before liver biopsyB G Gazzard, J M Henderson, R WilliamsAIDS (London, England)|February 1, 1997
Itraconazole cyclodextrin solution: the role of in vitro susceptibility testing in predicting successful treatment of HIV-related fluconazole-resistant and fluconazole-susceptible oral candidosisJ D Cartledge, J Midgley, B G GazzardPostgraduate Medical Journal|March 1, 1986
Detection of hepatic encephalopathyB G Gazzard, H Price, A M DawsonGut|July 1, 1976
Factor VII levels as a guide to prognosis in fulminant hepatic failureB G Gazzard, J M Henderson, R WilliamsGenitourinary Medicine|May 16, 1998
Prior fluconazole exposure as an independent risk factor for fluconazole resistant candidosis in HIV positive patients: a case-control studyJ D Cartledge, J Midgley, B G GazzardDrugs|May 1, 1996
Current knowledge and future prospects for the use of HIV protease inhibitorsG Moyle, B GazzardLancet (London, England)|August 5, 1998
1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing CommitteeB Gazzard, G MoyleExpert Opinion on Investigational Drugs|February 1, 1997
To sequence or not to sequence?B Gazzard, G MoylePageof 91